William L. Macias
Chief Tech/Sci/R&D Officer chez IMMUNOVANT, INC.
Fortune : 12 M $ au 31/03/2024
Profil
William L.
Macias is currently the Senior Medical Director at Lilly Research Laboratories, Director at Immunetrics, Inc., and Chief Medical Officer at Immunovant, Inc. He was previously the Chief Executive Officer at Focus Biomedical Consulting LLC from 2018 to 2021, Chief Medical Officer at PROMETHERA Biosciences SA from 2019 to 2020, and an Associate Professor at The Indiana University School of Medicine.
Macias received his undergraduate degree from Marquette University and his doctorate from The Indiana University School of Medicine.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
IMMUNOVANT INC
0,27% | 02/04/2024 | 385 930 ( 0,27% ) | 12 M $ | 31/03/2024 |
Postes actifs de William L. Macias
| Sociétés | Poste | Début |
|---|---|---|
| IMMUNOVANT, INC. | Chief Tech/Sci/R&D Officer | 01/06/2021 |
Lilly Research Laboratories
 Lilly Research Laboratories Miscellaneous Commercial ServicesCommercial Services Part of Eli Lilly & Co., Lilly Research Laboratories is a private company that engages in research and develops medicines. The company is based in Indianapolis, IN. | Corporate Officer/Principal | - |
Immunetrics, Inc.
 Immunetrics, Inc. BiotechnologyHealth Technology Immunetrics, Inc. operates as a bio-simulation company. The company was founded by Carson Chow, Timothy R. Billiar, Gilles Clermont, Mitchell P. Fink and Yoram Vodovotz in 2001 and is headquartered in Pittsburgh, PA. | Director/Board Member | - |
Anciens postes connus de William L. Macias
| Sociétés | Poste | Fin |
|---|---|---|
| Focus Biomedical Consulting LLC | Chief Executive Officer | 01/05/2021 |
PROMETHERA Biosciences SA
 PROMETHERA Biosciences SA Pharmaceuticals: MajorHealth Technology PROMETHERA Biosciences SA discovers, develops and commercializes cell therapy products to treat liver diseases. It operates as a pharmaceutical company that develops treatment based on allogeneic adult stem cell technology. The firm’s technology platform is based on a newly discovered cell type, isolated from normal human adult liver tissue: Heterologous Human Adult Liver Progenitor Cells (HHALPC). The company was founded by Etienne Marc Sokal and Eric Halioua on February 12, 2009 and is headquartered in Mont-Saint-Guibert, Belgium. | Chief Tech/Sci/R&D Officer | 01/01/2020 |
| The Indiana University School of Medicine | Corporate Officer/Principal | - |
Formation de William L. Macias
| Marquette University | Undergraduate Degree |
| The Indiana University School of Medicine | Doctorate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| IMMUNOVANT, INC. | Health Technology |
| Entreprise privées | 4 |
|---|---|
Lilly Research Laboratories
Lilly Research Laboratories Miscellaneous Commercial ServicesCommercial Services Part of Eli Lilly & Co., Lilly Research Laboratories is a private company that engages in research and develops medicines. The company is based in Indianapolis, IN. | Commercial Services |
Immunetrics, Inc.
Immunetrics, Inc. BiotechnologyHealth Technology Immunetrics, Inc. operates as a bio-simulation company. The company was founded by Carson Chow, Timothy R. Billiar, Gilles Clermont, Mitchell P. Fink and Yoram Vodovotz in 2001 and is headquartered in Pittsburgh, PA. | Health Technology |
PROMETHERA Biosciences SA
PROMETHERA Biosciences SA Pharmaceuticals: MajorHealth Technology PROMETHERA Biosciences SA discovers, develops and commercializes cell therapy products to treat liver diseases. It operates as a pharmaceutical company that develops treatment based on allogeneic adult stem cell technology. The firm’s technology platform is based on a newly discovered cell type, isolated from normal human adult liver tissue: Heterologous Human Adult Liver Progenitor Cells (HHALPC). The company was founded by Etienne Marc Sokal and Eric Halioua on February 12, 2009 and is headquartered in Mont-Saint-Guibert, Belgium. | Health Technology |
| Focus Biomedical Consulting LLC |
